🇺🇸 FDA
Patent

US 10420747

Cancer treatment method using ailanthone compounds

granted A61KA61K31/352A61K31/366

Quick answer

US patent 10420747 (Cancer treatment method using ailanthone compounds) held by EAST CHINA NORMAL UNIVERSITY expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EAST CHINA NORMAL UNIVERSITY
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/352, A61K31/366